1.
Efficacy and Tolerability of Valganciclovir 6 Months vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial. CLINICMED. 2022;3(1):18-25. doi:10.24018/clinicmed.2022.3.1.122